ANI Pharma launches generic Prochlorperazine maleate tablets

Aug. 29, 2022 9:00 AM ETANI Pharmaceuticals, Inc. (ANIP)By: Dania Nadeem, SA News Editor

Pharmaceutical industry production line

Maxiphoto/iStock via Getty Images

  • ANI Pharma (NASDAQ:ANIP) on Monday announced the launch of generic Prochlorperazine Maleate Tablets, 5 mg and 10 mg.
  • ANI's Prochlorperazine Maleate Tablets are the generic version of Compazine, which used to treat o treat severe nausea or vomiting, and were developed in technical collaboration with Biophore India Pharma.
  • The current annual U.S. market for Prochlorperazine Maleate Tablets is about $30M, according to IQVIA/IMS Health, the company said.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.